Manufacturer: Ferring Pharmaceuticals
Salt Composition : Urofollitropin(75i.u)
Bravelle 75I.U Injection is given as an injection under the supervision of a doctor. Your doctor or nurse will help you to learn the exact method of self-administration. Your doctor will decide the right time to take the injection, so always follow your doctor's advice. The dose and how often you take it depends on what you are taking it for. You might be prescribed with certain other medicine as a part of your treatment. You should take this medicine for as long as it is prescribed for you.
Bravelle 75I. U Injection works by stimulating the release of estrogen which helps in the growth and development of the egg before release. It also helps to develop more follicles (eggs) in women undergoing assisted reproductive technology procedures.
Urofollitropin is a form of purified human follicle stimulating hormone used to treat infertility in females by inducing follicle development in women without primary ovarian failure. Urofollitropin is a urinary-derived follicle-stimulating hormone (FSH) that is extracted and purified from human urine samples.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Bravelle
Abdominal pain
Headache
Bloating
Pelvic pain
Abdominal cramp
Nausea
Respiratory disorder
Hot flushes
cancer of the uterus.
cancer of the ovary.
cancer of the testis.
a tumor of the pituitary gland.
tumor that is dependent on estrogen for growth.
untreated decreased level of thyroid hormones.
severely decreased function of cortex of adrenal gland.
increased risk of blood clotting.
Bravelle 75I.U Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
It is unsafe to consume alcohol with Bravelle 75I.U Injection.
Information regarding the use of Bravelle 75I.U Injection during breastfeeding is not available. Please consult your doctor.
Use with caution
Below 9years: Contraindicated
Urofollitropin given in a sequential manner are indicated for the stimulation of follicular recruitment and development and the induction of ovulation in patients with polycystic ovary syndrome and infertility, who have failed to respond or conceive following adequate clomiphene citrate therapy.
If you have hyperprolactinemia (high levels of prolactin hormone), tumours of the pituitary gland, hypothalamus, uterus, breasts or ovaries, underactive adrenal or thyroid glands, vaginal bleeding, uterus fibroids, blood clots, early menopause, malformations of sexual organs, cysts on ovaries or enlarged ovaries, inform your doctor before taking UROFOLLITROPIN.
Kindly do not self administer.
Store in a refrigerator (2 - 8°C). Do not freeze.
If you miss a dose of Bravelle 75I.U Injection, please consult your doctor.
Consult a doctor before taking any medicines.
Your doctor may prescribe more than one medicine as part of a pregnancy plan.
The injection is administered under the skin. Follow the recommended dosage and monitoring schedules to minimise the possibility of ovarian hyperstimulation.
Inform your doctor immediately if you have severe pelvic pain, nausea, vomiting, diarrhea, sudden weight gain, trouble breathing, or decreased or no urination during treatment, as these could be symptoms of ovarian hyperstimulation syndrome (OHSS).
Do not use Bravelle 75I.U Injection if you are already pregnant or breastfeeding.
Pregnancy following treatment with Bravelle 75I.U Injection is more likely to result in a multiple pregnancy (twins or more) than if you had conceived naturally.
Bravelle 75I.U Injection stimulates the production of eggs in women having treatment for anovulatory infertility.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Q. How and in what dose should I take Bravelle 75I.U Injection?
It is given as an injection just under the skin by a medical healthcare professional only. The dose and treatment duration depends on your ovarian response for which you would be constantly monitored by your doctor during the treatment.
Q. What if I miss a dose of Bravelle 75I.U Injection?
Ideally, you should try not to miss a dose of Bravelle 75I.U Injection. However, please talk to your doctor as soon as you remember that you have missed a dose.
Q. What are the side effects of using Bravelle 75I.U Injection?
The most common side effects are headache and pain in the abdomen. The other common side effects include hot flushes, nausea, vomiting, diarrhea, rashes and breast tenderness. If any of these side effects bother you, please consult with your doctor. In addition, this medicine may increase the likelihood of conditions like ovarian hyperstimulation syndrome (OHSS) and multiple pregnancy.
Q. What is Bravelle 75I.U Injection, and what is it used for?
Bravelle 75I.U Injection contains a medicine called Urofollitropin. Urofollitropin is a type of follicle stimulating hormone (FSH). It helps to treat women who can not become pregnant because their ovaries do not produce eggs [including polycystic ovary disease (PCOD)]. It is also used in assisted reproductive technology (ART) procedures such as in-vitro fertilization (IVF), which help women to become pregnant.
